Opposite effect of stable transfection of bioactive transforming growth factor-beta 1 (TGF beta 1) versus exogenous TGF beta 1 treatment on expression of 92-kDa type IV collagenase in mouse skin squamous cell carcinoma CH72 cells.

doi:10.1002/(sici)1098-2744(199707)19:2<122::aid-mc7>3.0.co;2-h

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Back to search

Article

Opposite effect of stable transfection of bioactive transforming growth factor-beta 1 (TGF beta 1) versus exogenous TGF beta 1 treatment on expression of 92-kDa type IV collagenase in mouse skin squamous cell carcinoma CH72 cells.

Molecular carcinogenesis - 1 Jun 1997

Rundhaug J E, Park J, Pavone A, Opdenakker G, Fischer S M

Abstract excerpt

We have previously shown that transforming growth factor-beta 1 (TGF beta 1) mRNA is consistently overexpressed in squamous cell carcinomas relative to normal mouse skin. Here we show that 92-kDa type IV collagenase (matrix metalloproteinase) (MMP-9) mRNA was likewise progressively overexpressed...

Topics

Animals
Antibodies, Blocking
Blotting, Northern
Carcinoma, Squamous Cell
Collagenases
Dose-Response Relationship, Drug
Female
Matrix Metalloproteinase 9
Mice
Mice, Nude
Mutation
Papilloma
RNA, Messenger
Skin Neoplasms

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Time Factors

Transfection

Transforming Growth Factor beta

Tumor Cells, Cultured

Source

Open in PubMed

Identifiers

PMID: 9210959
DOI: 10.1002/(sici)1098-2744(199707)19:2<122::aid-mc7>3.0.co;2-h

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 30 Aug 2026. Prepared record publication-9210959-2026-08-30.1. Manifest publication-graph-cohort-2026-08-30.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 30 Aug 2026.